Previous genetic studies have shown that the NF-kB signaling pathway is constitutively activated in patients with CLL and disrupts the control of apoptosis and proliferation of tumor cells, causing their increased proliferation [32]. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.